Your browser doesn't support javascript.
loading
A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer.
Fankhauser, Christian D; Parry, Matthew G; Ali, Adnan; Cowling, Thomas E; Nossiter, Julie; Sujenthiran, Arun; Berry, Brendan; Morris, Melanie; Aggarwal, Ajay; Payne, Heather; van der Meulen, Jan; Clarke, Noel W.
Afiliación
  • Fankhauser CD; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; University of Zurich, Zurich, Switzerland; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland. Electronic address: cdfankhauser
  • Parry MG; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, GU Cancer/FASTMAN Resear
  • Ali A; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; GU Cancer/FASTMAN Research Group, Manchester University, Manchester, United Kingdom.
  • Cowling TE; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, GU Cancer/FASTMAN Research Group, Manchester University, Manchester, United Kingdom.
  • Nossiter J; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, GU Cancer/FASTMAN Resear
  • Sujenthiran A; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom.
  • Berry B; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, GU Cancer/FASTMAN Resear
  • Morris M; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, GU Cancer/FASTMAN Resear
  • Aggarwal A; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, GU Cancer/FASTMAN Resear
  • Payne H; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Department of Clinical Oncology University College London Hospital NHS Trust, London, United Kingdom.
  • van der Meulen J; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, GU Cancer/FASTMAN Resear
  • Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Department of Urology, Salford Royal NHS Foundation Trust, Manchester, UK.
Eur J Cancer ; 181: 70-78, 2023 03.
Article en En | MEDLINE | ID: mdl-36641896
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Braquiterapia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Braquiterapia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido